Skip to main content

PCRX

Pacira BioSciences, Inc.

Company with tickers: PCRX

Market Cap
$947.89M
Shares Outstanding
39,347,924
CIK
1396814
CUSIP
695127100
13F Activity (30d)
8 filings 4 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Past events

Date Event Type
2026-06-08 Goldman Sachs 47th Annual Global Healthcare Conference 2026 Conference
2026-06-03 2026 Jefferies Global Healthcare Conference Conference
2026-05-20 2026 RBC Capital Markets Global Healthcare Conference Conference
2026-04-30 Q1 2026 Pacira BioSciences, Inc. Earnings Conference Call Earnings call
2026-04-15 25th Annual Needham Virtual Healthcare Conference Conference
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-02-26 Q4 2025 Pacira BioSciences, Inc. Earnings Conference Call Earnings call
2026-01-14 44th Annual J.P. Morgan Healthcare Conferences Conference
2025-12-02 37th Annual Piper Sandler Healthcare Conference Conference
2025-11-18 Jefferies London Healthcare Conference Conference
2025-11-06 Q3 2025 Pacira BioSciences, Inc. Earnings Conference Call Earnings call
2025-08-05 Q2 2025 Pacira BioSciences, Inc. Earnings Conference Call Earnings call
2025-06-04 2025 Jefferies Global Healthcare Conference Conference
2025-05-21 2025 RBC Capital Markets Global Healthcare Conference Conference
2025-05-08 Q1 2025 Pacira BioSciences, Inc. Earnings Conference Call Earnings call
2025-04-21 PCRX-201 Clinical Development Plan: Innovative Gene Therapy Targeting Underlying Cause of Osteoarthritis Event
2025-04-07 24th Annual Needham Virtual Healthcare Conference Conference
2025-03-12 Barclays 27th Annual Global Healthcare Conference Conference
2025-03-05 Raymond James 46th Annual Institutional Investors Conference Conference
2025-02-27 Q4 2024 Pacira BioSciences, Inc. Earnings Conference Call Earnings call
2024-11-17 ACR Convergence 2024: PCRX-201 2-Year Data Event
2024-11-05 An Introduction to PCRX-201: Developing a Transformative Innovation in Treatment of Knee OA Event